Averting opioid-induced respiratory depression without affecting analgesia.

A Dahan, R van der Schrier, T Smith, L Aarts… - …, 2018 - europepmc.org
The ventilatory control system is highly vulnerable to exogenous administered opioid
analgesics. Particularly respiratory depression is a potentially lethal complication that may …

Animal models in translational studies of PTSD

NP Daskalakis, R Yehuda, DM Diamond - Psychoneuroendocrinology, 2013 - Elsevier
Understanding the neurobiological mechanisms of post-traumatic stress disorder (PTSD) is
of vital importance for developing biomarkers and more effective pharmacotherapy for this …

Antidepressants act by inducing autophagy controlled by sphingomyelin–ceramide

A Gulbins, F Schumacher, KA Becker, B Wilker… - Molecular …, 2018 - nature.com
Major depressive disorder (MDD) is a common and severe disease characterized by mood
changes, somatic alterations, and often suicide. MDD is treated with antidepressants, but the …

[HTML][HTML] Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs

E Gulbins, M Palmada, M Reichel, A Lüth, C Böhmer… - Nature medicine, 2013 - nature.com
Major depression is a highly prevalent severe mood disorder that is treated with
antidepressants. The molecular targets of antidepressants require definition. We …

Reports of adverse events associated with use of novel psychoactive substances, 2017–2020: a review

ALA Mohr, BK Logan, MF Fogarty… - Journal of Analytical …, 2022 - academic.oup.com
An important role of modern forensic and clinical toxicologists is to monitor the adverse
events of novel psychoactive substances (NPS). Following a prior review from 2013 to 2016 …

Inhibition of serotonin synthesis: A novel therapeutic paradigm

M Bader - Pharmacology & therapeutics, 2020 - Elsevier
The rate-limiting enzyme in serotonin synthesis is tryptophan hydroxylase (TPH). There are
two independent serotonin systems in the body characterized by two isoforms of TPH, TPH1 …

Stress induces major depressive disorder by a neutral sphingomyelinase 2-mediated accumulation of ceramide-enriched exosomes in the blood plasma

F Schumacher, A Carpinteiro, MJ Edwards… - Journal of Molecular …, 2022 - Springer
Major depressive disorder (MDD) is a very common, severe disease with a lifetime
prevalence of~ 10%. The pathogenesis of MDD is unknown and, unfortunately, therapy is …

Ceramide levels in blood plasma correlate with major depressive disorder severity and its neutralization abrogates depressive behavior in mice

F Schumacher, MJ Edwards, C Mühle… - Journal of Biological …, 2022 - ASBMB
Major depressive disorder (MDD) is a severe disease of unknown pathogenesis that will
affect∼ 10% of people during their lifetime. Therapy for MDD requires prolonged treatment …

A review of biomarkers in mood and psychotic disorders: a dissection of clinical vs. preclinical correlates

SJ Brand, M Moller, BH Harvey - Current neuropharmacology, 2015 - ingentaconnect.com
Despite significant research efforts aimed at understanding the neurobiological
underpinnings of mood (depression, bipolar disorder) and psychotic disorders, the …

New molecular targets for antidepressant drugs

J Kornhuber, E Gulbins - Pharmaceuticals, 2021 - mdpi.com
Major depressive disorder (MDD) is a common and severe mental disorder that is usually
recurrent and has a high risk of suicide. This disorder manifests not only with psychological …